KA Imaging gets FDA clearance for Reveal X-ray detector
KA Imaging said that Reveal, its portable dual-energy X-ray detector has been granted 510(k) clearance from the US…
Evonetix, Analog Devices join forces for third gen DNA synthesis platform
Evonetix, a synthetic biology company, which is engaged in developing a desktop platform for rapid gene synthesis, has…
Takeda to sell select non-core assets to Cheplapharm for $562m
Takeda Pharmaceutical has agreed to sell a portfolio of certain non-core prescription pharma products sold mainly in Europe…
Freudenberg Medical acquires hypotube manufacturing business of Merit Medical Systems
Freudenberg Medical has acquired the manufacturing equipment and associated assets used by Merit Medical Systems in its hypotube…
RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211
RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for…
FDA accepts Ascendis Pharma’s TransCon hGH BLA for pediatric GHD
Ascendis Pharma, a Danish biopharma company, said that the US Food and Drug Administration (FDA) has accepted its…
Nestlé to fully own Aimmune Therapeutics through $2bn deal
NestlĂ© will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by…
Ionis Pharmaceuticals to take full ownership of Akcea Therapeutics
Ionis Pharmaceuticals is set to take full ownership of Akcea Therapeutics by acquiring the remaining stake of around…
Rocket Pharmaceuticals gets FDA fast track status for RP-L401 in infantile malignant osteopetrosis
Rocket Pharmaceuticals has secured fast track designation for RP-L401 gene therapy candidate from the US Food and Drug…
Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases
Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases,…